Science Corp. Raises $230M As It Races To Bring Its Brain Implant To Market
Brain implant startup Science Corp. raises $230M at a $1.5B valuation, racing to bring its vision-restoring chip to market by mid-2026.
Matilda
Science Corp. Raises $230M As It Races To Bring Its Brain Implant To Market
A brain-computer interface startup co-founded by a former Neuralink executive just secured $230 million in new funding — and it may be closer to putting a product in patients' hands than anyone in the industry. Science Corporation, led by Max Hodak, is betting that a rice-grain-sized eye implant will make it the first BCI company to actually reach the market. Here's what you need to know. The $230 Million Bet on Brain-Computer Interface Technology
Science Corporation announced Wednesday that it has closed a $230 million Series C funding round. According to a source close to the company, the round values Science Corp. at $1.5 billion post-money — a striking figure for a startup operating in one of biotech's most complex and competitive spaces. The brain-computer interface sector has long been viewed as a moonshot territory, drawing headlines but few concrete clinical results. While the broader venture capital world has spent the last two years chasing artificial intelligence …
